Follow-up Ultrasound for Arm DVT on Rivaroxaban and Aspirin
Indications for Follow-up Ultrasound
- The American College of Cardiology recommends a follow-up ultrasound at or near the end of anticoagulation therapy for patients with arm DVT treated with rivaroxaban and aspirin to establish a new baseline and determine if scarring is present 1, 2
- Routine ultrasound during adequate anticoagulation therapy is not recommended unless it will change the patient's treatment, as stated by the American Heart Association 1
- Repeat ultrasound is warranted if the patient develops persistent or worsening symptoms despite anticoagulation therapy, according to the American College of Cardiology 1, 3
Rationale for Limited Follow-up During Therapy
- The primary goal of diagnostic testing for DVT is to identify patients who will benefit from anticoagulant therapy, not to document complete resolution, as stated by the American College of Chest Physicians 5
- Clinical response to therapy (symptom improvement) is a more practical indicator of treatment success than imaging resolution, according to the American Society of Hematology 3
Special Considerations for Arm DVT
- The same principles for follow-up imaging apply to upper extremity DVT as to lower extremity DVT, as stated by the American College of Cardiology 3
- Upper extremity DVT may have different resolution patterns than lower extremity DVT, but the recommendation for follow-up imaging at the end of therapy remains consistent, according to the American Heart Association 1
Interpreting Follow-up Ultrasound Results
- Abnormalities should be classified into acute venous thrombosis, chronic postthrombotic change, or indeterminate (equivocal), as stated by the American College of Cardiology 2
- Recurrent DVT may appear as acute thrombus in a previously normal vein or acute thrombus on areas of scarring, according to the American College of Cardiology 2